Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

Abstract Background Shende’an tablet (SDA) is a newly capsuled Chinese herbal formula derived from the Chinese traditional medicine Zhengan Xifeng Decoction which is approved for the treatment of neurasthenia and insomnia in China. This study aimed to investigate the neuroprotective effects of SDA a...

Full description

Bibliographic Details
Main Authors:	Xiaoyan Sheng, Shuiyuan Yang, Xiaomin Wen, Xin Zhang, Yongfeng Ye, Peng Zhao, Limin Zang, Kang Peng, Enming Du, Sai Li
Format:	Article
Language:	English
Published:	BMC 2021-02-01
Series:	Chinese Medicine
Subjects:	Shende’an tablet Parkinson’s disease Neuroprotection α-Synuclein PGC-1α Nrf2
Online Access:	https://doi.org/10.1186/s13020-021-00429-y

Similar Items

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity
by: Wojciech Bobela, et al.
Published: (2017-11-01)

Etude des effets neuroprotecteurs des stilbènes de la vigne sur la maladie de Parkinson
by: Temsamani, Hamza
Published: (2015)

Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity
by: Kelley C. O’Donnell, et al.
Published: (2014-05-01)

Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
by: Anna Wilkaniec, et al.
Published: (2021-02-01)

The Anti-Diabetic Drug Metformin Rescues Aberrant Mitochondrial Activity and Restrains Oxidative Stress in a Female Mouse Model of Rett Syndrome
by: Ilaria Zuliani, et al.
Published: (2020-06-01)

Neuroprotective function of Omi to α-synuclein-induced neurotoxicity
by: Hea-Jong Chung, et al.
Published: (2020-03-01)

Catecholamines and Neurodegeneration in Parkinson’s Disease—From Diagnostic Marker to Aggregations of α-Synuclein
by: Kenji Yamamoto, et al.
Published: (2013-03-01)

From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
by: Andrea Mancini, et al.
Published: (2020-07-01)

Songorine promotes cardiac mitochondrial biogenesis via Nrf2 induction during sepsis
by: Yi Li, et al.
Published: (2021-01-01)

Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1α Signaling Pathways
by: Artem P. Gureev, et al.
Published: (2019-05-01)

Neuroprotective Effects and Related Mechanisms of Echinacoside in MPTP-Induced PD Mice
by: Zhang ZN, et al.
Published: (2021-06-01)

IDENTIFICATION OF HUMAN PGC-1α-b ISOFORMS USING A NOVEL PGC-1α-b SPECIFIC ANTIBODY
by: Hedrick, Shannon
Published: (2013)

Long-Term Aspartame Administration Leads to Fibrosis, Inflammasome Activation, and Gluconeogenesis Impairment in the Liver of Mice
by: Isabela A. Finamor, et al.
Published: (2021-01-01)

The soybean bioactive peptide VHVV alleviates hypertension-induced renal damage in hypertensive rats via the SIRT1-PGC1α/Nrf2 pathway
by: Bruce Chi-Kang Tsai, et al.
Published: (2020-12-01)

Early Exercise Affects Mitochondrial Transcription Factors Expression after Cerebral Ischemia in Rats
by: Yongshan Hu, et al.
Published: (2012-02-01)

γ-Mangostin, a xanthone from mangosteen, attenuates oxidative injury in liver via NRF2 and SIRT1 induction
by: Anqi Wang, et al.
Published: (2018-01-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
by: Hayate Javed, et al.
Published: (2019-03-01)

DMEP induces mitochondrial damage regulated by inhibiting Nrf2 and SIRT1/PGC-1α signaling pathways in HepG2 cells
by: Huan Liu, et al.
Published: (2021-09-01)

Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis
by: Fatima M. Shakova, et al.
Published: (2021-03-01)

Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons
by: Cabeza-Arvelaiz Yofre, et al.
Published: (2011-12-01)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01)

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
by: Yasushi Yabuki, et al.
Published: (2020-03-01)

The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism
by: Dong-Kug Choi, et al.
Published: (2012-08-01)

COMPARISON EFFECT BETWEEN PEGAGAN (Centella asiatica) EXTRACT AND PRAMIPEXOLE TOWARD LOCOMOTOR ACTIVITIES, α - SYNUCLEIN, AND NRF2 EXPRESSION IN ZEBRAFISH PARKINSON MODEL
by: Ayu Trisnawati, et al.
Published: (2018-10-01)

Brain Region Specificity of Mitochondrial Biogenesis and Bioenergetics Response to Nrf2 Knockdown: A Comparison Among Hippocampus, Prefrontal Cortex and Amygdala of Male Rat Brain
by: Solmaz Khalifeh, et al.
Published: (2017-08-01)

Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease
by: Jiaolong Yang, et al.
Published: (2021-01-01)

miR-373 Suppresses Cell Proliferation and Apoptosis via Regulation of SIRT1/PGC-1α/NRF2 Axis in Pancreatic Cancer
by: Qing-Hua Yin, et al.
Published: (2021-07-01)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
by: Oeystein R. Brekk, et al.
Published: (2020-08-01)

Senkyunolide A protects neural cells against corticosterone-induced apoptosis by modulating protein phosphatase 2A and α-synuclein signaling
by: Gong S, et al.
Published: (2018-06-01)

Development of the Composition and Technology of New Neuroprotective Drug Tablets Using Fractional Factorial Design
by: O. A. Terenteva, et al.
Published: (2020-02-01)

Neuroprotective Effects of Metformin Versus Selegiline on Parkinson’s Disease Model By Reserpine through the Interrelation of α Synuclein and Antioxidants on Behavioral Changes in Rats
by: Ghada Farouk Soliman, et al.
Published: (2019-11-01)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
by: Chin-Hsien Lin, et al.
Published: (2019-10-01)

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise
by: Simona Daniele, et al.
Published: (2018-01-01)

Efforts to overcome hypoxia condition in Balb/c mouse macrophages after intraperitoneal SRBC immunization
by: Pungguri Ayu Nega Sarsanti, et al.
Published: (2019-05-01)

Hyperglycemia aggravates decrease in alpha-synuclein expression in a middle cerebral artery occlusion model
by: Ju-Bin Kang, et al.
Published: (2018-12-01)

c-Abl inhibitors enable insights into the pathophysiology and neuroprotection in Parkinson’s disease
by: Dan Lindholm, et al.
Published: (2016-10-01)

L-Asparaginase Exerts Neuroprotective Effects in an SH-SY5Y-A53T Model of Parkinson’s Disease by Regulating Glutamine Metabolism
by: Qingxi Zhang, et al.
Published: (2020-09-01)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01)